# Low-Dose Liposomal Amphotericin B for Invasive Fungal Infection Prophylaxis in Neutropenic Children

> **NCT07725263** · — · RECRUITING · sponsor: **Haikou Affiliated Hospital of Central South University Xiangya School of Medicine** · enrollment: 30 (estimated)

## Conditions studied

- Thalassemia
- Hematopoietic Stem Cell Transplantation
- Neutropenia
- Invasive Fungal Infections
- Graft vs Host Disease

## Interventions

- **DRUG:** Liposomal Amphotericin B (LAmB)

## Key facts

- **NCT ID:** NCT07725263
- **Lead sponsor:** Haikou Affiliated Hospital of Central South University Xiangya School of Medicine
- **Sponsor class:** OTHER
- **Phase:** —
- **Study type:** OBSERVATIONAL
- **Status:** RECRUITING
- **Start date:** 2026-02-01
- **Primary completion:** 2027-02-28
- **Final completion:** 2027-03-31
- **Target enrollment:** 30 (ESTIMATED)
- **Last updated:** 2026-07-24


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT07725263

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT07725263, "Low-Dose Liposomal Amphotericin B for Invasive Fungal Infection Prophylaxis in Neutropenic Children". Retrieved via MORVS 2026-10-20 from https://api.morvs.ai/clinical/NCT07725263. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*